Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,816.00    -12.00 (-0.42%)
Bid:
2,814.00
Ask:
2,818.00
Spread: 4.00 (0.142%)
Market Cap: £6.70b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Share repurchase programme

26 Apr 2021 11:23

RNS Number : 6001W
IMI PLC
26 April 2021
 

26 April 2021

IMI plc

LEI: 2138002W9Q21PF751R30

Share repurchase programme

IMI plc (the Company) announces that, in connection with the 12 month share buyback programme of up to £200 million which it announced on 26 April 2021, it is commencing a share buyback programme (the Programme) to purchase shares with a value of up to £100 million subject to remaining within the AGM authority (the 2020 AGM authority is for a maximum of 27,200,000 shares) during the period starting on 26 April 2021 and ending no later than 4 August 2021 (the Engagement Period) in order to reduce the capital of the Company. Shares purchased pursuant to the Programme will be cancelled. The Company has entered into an agreement with J.P. Morgan Securities plc (JPMS plc) under which it has issued an irrevocable instruction to JPMS plc to manage the share buyback programme. JPMS plc will carry out the instruction through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. This arrangement is in accordance with Chapter 12 of the FCA's Listing Rules and the Company's general authority to repurchase shares. The Programme will also be effected within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (in each case, as in force in the UK from time to time as retained EU law (as defined in the European Union (Withdrawal) Act 2018 as amended from time to time), including where relevant pursuant to the Market Abuse (Amendment)(EU Exit) Regulations 2019). JPMS plc may undertake transactions in shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the Engagement Period in order to manage its market exposure under the Programme. Disclosure of such transactions will not be made by JPMS plc as a result of or as part of the Programme, but JPMS plc will continue to make any disclosures it is otherwise legally required to make.

 

Enquiries to:

 

John O'Shea

IMI

Tel: +44 (0)121 717 3780

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSEUFSMEFSEFL
Date   Source Headline
31st Mar 202110:42 amRNSDirector/PDMR Shareholding
26th Mar 20213:38 pmRNSAnnual Financial Report
23rd Mar 20211:52 pmRNSDirector/PDMR Shareholding
23rd Mar 202110:56 amRNSDirector Declaration
19th Mar 20214:17 pmRNSDirector/PDMR Shareholding
10th Mar 202112:23 pmRNSDirector/PDMR Shareholding
1st Mar 202110:09 amRNSTotal Voting Rights
26th Feb 20219:04 amRNSHolding(s) in Company
26th Feb 20217:08 amRNSNew non-executive director appointed
26th Feb 20217:00 amRNSPreliminary results, year ended 31 December 2020
17th Feb 20216:13 pmRNSHolding(s) in Company
15th Feb 20214:17 pmRNSHolding(s) in Company
10th Feb 202112:38 pmRNSDirector/PDMR Shareholding
1st Feb 202110:26 amRNSTotal Voting Rights
13th Jan 202111:29 amRNSDirector/PDMR Shareholding
5th Jan 202110:04 amRNSBlock listing Interim Review
4th Jan 202110:54 amRNSTotal Voting Rights
9th Dec 202010:16 amRNSDirector/PDMR Shareholding
1st Dec 20209:24 amRNSTotal Voting Rights
11th Nov 202011:26 amRNSDirector/PDMR Shareholding
2nd Nov 20209:29 amRNSTotal Voting Rights
28th Oct 20207:00 amRNSInterim Management Statement
14th Oct 202012:07 pmRNSDirector/PDMR Shareholding
1st Oct 20209:33 amRNSTotal Voting Rights
9th Sep 20205:04 pmRNSDirector/PDMR Shareholding
9th Sep 202012:32 pmRNSDirector/PDMR Shareholding
7th Sep 20209:07 amRNSHolding(s) in Company
1st Sep 202010:04 amRNSTotal Voting Rights
12th Aug 20204:01 pmRNSDirector/PDMR Shareholding
3rd Aug 20209:28 amRNSTotal Voting Rights
28th Jul 202011:33 amRNSDirector/PDMR Shareholding
24th Jul 20207:00 amRNSInterim results, six months ended 30 June 2020
17th Jul 20209:36 amRNSDirector/PDMR Shareholding - Replacement
15th Jul 20202:32 pmRNSDirector/PDMR Shareholding
2nd Jul 202011:37 amRNSBlock listing Interim Review
1st Jul 202010:30 amRNSTotal Voting Rights
10th Jun 202011:06 amRNSDirector/PDMR Shareholding
1st Jun 20209:11 amRNSTotal Voting Rights
20th May 20201:57 pmRNSHolding(s) in Company
13th May 20202:06 pmRNSDirector/PDMR Shareholding
7th May 20201:04 pmRNSResult of AGM
7th May 20207:00 amRNSInterim Management Statement & Coronavirus update
1st May 202010:03 amRNSTotal Voting Rights
30th Apr 20204:48 pmRNSHolding(s) in Company
27th Apr 20205:27 pmRNSDisclosure of rights attached to equity shares
21st Apr 20201:07 pmRNSChange of Venue for the 2020 AGM
21st Apr 202012:30 pmRNSDirector Declaration
16th Apr 20204:26 pmRNSHolding(s) in Company
15th Apr 20202:20 pmRNSDirector/PDMR Shareholding
14th Apr 20204:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.